The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
878
September 4, 1992
View Complete Issue         Table of Contents 2019 
Finasteride for Benign Prostatic Hypertrophy
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Finasteride for Benign Prostatic Hypertrophy
September 4, 1992 (Issue: 878)
Finasteride (Proscar - Merck) has now been approved by the US Food and Drug Administration (FDA) for oral treatment of benign prostatic hyperplasia. A 4-aza-steroid, the drug is a specific inhibitor of steroid 5 -reductase, the enzyme that...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Finasteride for Benign Prostatic Hypertrophy
Article code: 878a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.